# XILO-FIST, the Effect of Allopurinol on the Brain Heart and Blood Pressure After Stroke

Study · id `cardio:ct-nct02122718` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT02122718](<https://clinicaltrials.gov/study/NCT02122718>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT02122718

Browse, organ or system: Brain  
Browse, condition area: Stroke  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 464 participants.

## Technical summary

Registry record NCT02122718. Randomized; quadruple masking; primary purpose treatment. Start 2014-05 (registry gives no type); primary completion 2021-02 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase: Phase 4
- Enrolled: 464 participants (enrolled count; ClinicalTrials.gov record NCT02122718, source copy `cardio:ctgov-nct02122718-2021-11-12`, retrieved 2026-10-26)
- Start date: 2014-05 (registry gives no type) (ClinicalTrials.gov record NCT02122718, source copy `cardio:ctgov-nct02122718-2021-11-12`, retrieved 2026-10-26)
- Primary completion: 2021-02 (actual) (ClinicalTrials.gov record NCT02122718, source copy `cardio:ctgov-nct02122718-2021-11-12`, retrieved 2026-10-26)
- Completion: 2021-02 (actual) (ClinicalTrials.gov record NCT02122718, source copy `cardio:ctgov-nct02122718-2021-11-12`, retrieved 2026-10-26)
- Countries: United Kingdom (ClinicalTrials.gov record NCT02122718, source copy `cardio:ctgov-nct02122718-2021-11-12`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct02122718-2021-11-12`, retrieved 2026-10-26)

## The registry's words

- Brief title: XILO-FIST, the Effect of Allopurinol on the Brain Heart and Blood Pressure After Stroke
- Acronym: XILO-FIST
- Condition: Ischaemic Stroke
- Intervention (Drug): Allopurinol
- Intervention (Drug): Placebo
- Lead sponsor: NHS Greater Glasgow and Clyde
- Lead sponsor class: OTHER
- Collaborator: University of Glasgow
- Collaborator class: OTHER

## Connected pages

- Registry condition terms include this condition: Ischemic stroke (`cardio:ischemic-stroke`)
- Registry condition terms include this condition: Stroke (`core:stroke`)
- Registry lists this organization as the lead sponsor: NHS Greater Glasgow and Clyde (`cardio:org-nhs-greater-glasgow-and-clyde`)
- Registry lists this organization as a collaborator: University of Glasgow (`cardio:org-university-of-glasgow`)

## Provenance

Content hash: 32618e8ad6d6190dea5cfb1f74b129c7d26e4faf878fe416d993b23f990062eb
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
